K
Karim Bensalah
Researcher at University of Rennes
Publications - 246
Citations - 11264
Karim Bensalah is an academic researcher from University of Rennes. The author has contributed to research in topics: Medicine & Renal cell carcinoma. The author has an hindex of 43, co-authored 154 publications receiving 8773 citations. Previous affiliations of Karim Bensalah include University of Paris-Sud & Université de Montréal.
Papers
More filters
Journal ArticleDOI
EAU Guidelines on Renal Cell Carcinoma: 2014 Update
Börje Ljungberg,Karim Bensalah,Steven E. Canfield,Saeed Dabestani,Fabian Hofmann,Milan Hora,Markus A. Kuczyk,Thomas B. Lam,Lorenzo Marconi,Axel S. Merseburger,Peter F.A. Mulders,Thomas Powles,Michael Staehler,Alessandro Volpe,Axel Bex +14 more
TL;DR: The 2014 RCC guideline has been updated by a multidisciplinary panel using the highest methodological standards, and provides the best and most reliable contemporary evidence base for RCC management.
Journal ArticleDOI
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update.
Börje Ljungberg,Laurance Albiges,Yasmin Abu-Ghanem,Karim Bensalah,Saeed Dabestani,Sergio Fernández-Pello,Rachel H. Giles,Fabian Hofmann,Milan Hora,Markus A. Kuczyk,Teele Kuusk,Thomas B. Lam,Lorenzo Marconi,Axel S. Merseburger,Thomas Powles,Michael Staehler,Rana Tahbaz,Alessandro Volpe,Axel Bex +18 more
TL;DR: These guidelines provide the most reliable contemporary evidence base for the management of RCC in 2019 and are thoroughly evaluated to establish international standards for the care of kidney cancer patients.
Journal ArticleDOI
Epidemiology of Renal Cell Carcinoma.
Umberto Capitanio,Karim Bensalah,Axel Bex,Stephen A. Boorjian,Freddie Bray,Jonathan A. Coleman,John L. Gore,Maxine Sun,Christopher G. Wood,Paul Russo +9 more
TL;DR: Smoking, obesity, hypertension, and hypertension are most strongly associated with RCC, and the cost effectiveness of a screening programme needs to be assessed on a country-specific level due to geographic heterogeneity in incidence and mortality rates, costs, and management implications.
Journal ArticleDOI
Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy
Lorenzo Marconi,Saeed Dabestani,Thomas B. Lam,Fabian Hofmann,Fiona Stewart,John Norrie,Axel Bex,Karim Bensalah,Steven E. Canfield,Milan Hora,Markus A. Kuczyk,Axel S. Merseburger,Peter F.A. Mulders,Thomas Powles,Michael Staehler,Börje Ljungberg,Alessandro Volpe +16 more
TL;DR: The results suggest that RTB has good accuracy in diagnosing renal cancer and its subtypes, and it appears to be safe, but better quality studies are required to provide a more definitive answer.
Journal ArticleDOI
Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery.
Karim Bensalah,Allan J. Pantuck,Nathalie Rioux-Leclercq,Rodolphe Thuret,Francesco Montorsi,Pierre I. Karakiewicz,Nicolas Mottet,Laurent Zini,Roberto Bertini,Laurent Salomon,A. Villers,Michel Soulié,Laurent Bellec,Pascal Rischmann,Alexandre de la Taille,R. Avakian,Maxime Crepel,Jean Marie Ferriere,Jean-Christophe Bernhard,Thierry Dujardin,Frédéric Pouliot,Jérôme Rigaud,Christian Pfister,B. Albouy,Laurent Guy,Steven Joniau,Hendrik Van Poppel,Thierry Lebret,T. Culty,Fabien Saint,Amnon Zisman,Orit E. Raz,Herve Lang,Romain Spie,Andreas H. Wille,Jan Roigas,Alfredo Aguilera,Bastien Rambeaud,Luis Martinez Pineiro,Ofer Nativ,Roy Farfara,François Richard,Morgan Rouprêt,Christian Doehn,Patrick J. Bastian,Stefan C. Müller,Jacques Tostain,Arie S. Belldegrun,Jean Jacques Patard +48 more
TL;DR: PSM status occurs more frequently in cases in which surgery is imperative and is associated with an increased risk of recurrence, but PSM status does not appear to influence cancer-specific survival.